Last week I offered to “open the kimono” by answering pretty much anything (within reason) that readers cared to ask. Looks like in response, I got a couple of “nuts & bolts” questions on day-to-day D-stuff, along with one call for my perspective on the Big Picture. That one will take some soul-searching, so let me start with the easy stuff:
Reader Q) As a fellow OmniPodder, how do you manage scar tissue? I rotate…
Read more »
I personally wasn’t able to attend the annual meeting of the American Association of Diabetes Educators this summer. But I’ve been there a few times. It’s quite the experience for a patient to witness thousands of experts in life-with-diabetes running around between lectures, demos, and expo booths. What are they all buzzing about? Today, a wrap-up from Kelly Rawlings, a type 1 diabetic who happens to be editor of Meredith Publishing’s Diabetic Living magazine.
A…
Read more »
Second in our series of getting to know the judges of this year’s DiabetesMine Design Challenge, please say hello to Ross Jaffe, MD, a board-certified internist and eminent venture capitalist with Versant Ventures in Silicon Valley, CA. His job is to lead investments in medical devices, drug delivery, and healthcare information systems companies. He was a founding investor behind TheraSense and Insulet Corp. (the OmniPod company), so he knows a thing or two about innovation…
Read more »
It’s that time again. Another year has passed, and one can’t help wondering: was there any significant progress made in the diabetes world? I guess if you only count “progess” as steps towards a cure, that’s a difficult question to answer. For what it’s worth, here’s my own list of milestone events that occurred this year:
♦ The ACCORD study results were announced, and interpreted to sound like tight blood glucose control might kill you…
Read more »